Skip to content

Sofosbuvir/ledipasvir plus ribavirin shows high cure rate for hepatitis C patients with advanced liver disease

Michael Manns of Hannover Medical School presenting results of the SOLAR study. Photo by Liz Highlyeman, hivandhepatitis.com

Merck HCV combination achieves 90% cure in advanced cirrhosis

Dr Ira Jacobson of Weill-Cornell Medical College presents results of the C-SALT study. Photo by Liz Highleyman, hivandhepatitis.com

Merck HCV combination effective after failure of first generation of direct-acting antivirals

Dr Xavier Forns of Hospital Clinic, Barcelona, presents results of the C-SALVAGE study. Photo by Liz Highleyman, hivandhepatitis.com

Treatment outcomes no better with single tablet regimens than individual tablets

HCV viral load levels during treatment and speed of decline do not predict cure with interferon-free therapy

David Wyles presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Daily PrEP leads to better adherence and protective drug levels in women

High treatment failure rate among Thai children switching to second-line ART

Annual CD4 count monitoring may be sufficient for people doing well on HIV treatment

Newly adopted risk behaviours predict HIV infections in Portuguese gay men